Cardiovascular diseases: Heart disease Circulatory System Heart disease
Conditions
Interventions
Electrophysiology + implantable cardioverter defibrillators (ICDs) versus Amiodarone empirically
Sponsors
Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients who presented with sustained ventricular tachycardia (VT), ventricular fibrillation (VF) or sudden cardiac death (SCD) and survived to reach hospital within the Midlands from Feb 1997 to Jan 1999 were actively identified and entered into the study. 2. Patients who were not of child-bearing age or had a life-expectancy of <6 months from a non-arrhythmic cause were approached for entry into the trial. Patients who were ineligible for or refused to join the trial were entered into the study's registry.
Exclusion criteria
Exclusion criteria: Does not match inclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Death 2. Arrhythmia recurrence 3. Hospitalisation 4. Drug use 5. Quality of life 6. Cost of managing patients | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Countries
United Kingdom
Outcome results
None listed